Myriad Genetics
MYGN
MYGN
250 hedge funds and large institutions have $2.56B invested in Myriad Genetics in 2017 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 89 increasing their positions, 78 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.14% less ownership
Funds ownership: 109.98% → 107.84% (-2.1%)
6% less capital invested
Capital invested by funds: $2.72B → $2.56B (-$158M)
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
250
Holding in Top 10
2
Calls
$7.29M
Puts
$5.43M
Top Buyers
| 1 | +$30.8M | |
| 2 | +$29.7M | |
| 3 | +$16.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.9M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$12.9M |
Top Sellers
| 1 | -$71.4M | |
| 2 | -$25.1M | |
| 3 | -$17.2M | |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$14.5M |
| 5 |
Millennium Management
New York
|
-$11.2M |